Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel

NCT02249767 is registered in ClinicalTrials.gov with Spear Pharmaceuticals as lead sponsor.

NCT NCT02249767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02249767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel
Lead sponsor
Spear Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2013
Completion date
June 30, 2014
Enrollment
574 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acne